Commonwealth Retirement Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Sell
83,307
-10,599
-11% -$1.24M 2.91% 5
2026
Q1
$11.3M Buy
93,906
+1,906
+2% +$220K 3.5% 4
2025
Q4
$9.68M Sell
92,000
-1,003
-1% -$94.2K 3.12% 5
2025
Q3
$7.81M Buy
93,003
+4,336
+5% +$357K 2.65% 8
2025
Q2
$7.02M Buy
88,667
+63,295
+249% +$5.03M 2.67% 9
2025
Q1
$2.28M Sell
25,372
-90
-0.4% -$8.4K 0.93% 36
2024
Q4
$2.53M Sell
25,462
-377
-1% -$38.9K 1.04% 31
2024
Q3
$2.93M Sell
25,839
-1,930
-7% -$229K 1.23% 23
2024
Q2
$3.44M Sell
27,769
-27,720
-50% -$3.57M 1.57% 19
2024
Q1
$7.32M Sell
55,489
-3,326
-6% -$410K 3.5% 7
2023
Q4
$6.41M Sell
58,815
-2,240
-4% -$233K 3.4% 8
2023
Q3
$6.29M Sell
61,055
-128
-0.2% -$13.8K 3.63% 9
2023
Q2
$7.06M Buy
61,183
+646
+1% +$73.3K 3.94% 6
2023
Q1
$6.44M Buy
60,537
+878
+1% +$94.8K 3.82% 7
2022
Q4
$6.62M Buy
+59,659
New +$6.1M 4.01% 2

Other funds holding MRK

Commonwealth Retirement Investments's MRK Position: Q2 2026 in Review

Commonwealth Retirement Investments reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $1.24M and leaving 83,307 shares worth $10.7M. The position accounts for 2.91% of the portfolio, ranked #5.

Commonwealth Retirement Investments first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $11.3M in Q1 2026. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Commonwealth Retirement Investments held 83,307 shares of Merck worth $10.7M as of Q2 2026.
  • Commonwealth Retirement Investments sold 10,599 Merck shares in Q2 2026, an estimated $1.24M.
  • Merck made up 2.91% of Commonwealth Retirement Investments's portfolio in Q2 2026, its #5 holding.
  • Commonwealth Retirement Investments first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Commonwealth Retirement Investments's Merck position peaked at $11.3M in Q1 2026.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q2 2026, filed 3 Aug 2026.